Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Lindstrom

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|December 8, 1998
Heterogeneous expression of the lipocalin NGAL in primary breast cancersS P Stoesz, A Friedl, J D Haag, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 1994
The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitizationC J McGinn, E M Miller, M J Lindstrom, et al.
Cancer Research|September 15, 1993
Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometryJ N Sarkaria, D F Gibson, V C Jordan, et al.
Journal of Interferon Research|August 1, 1990
Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophagesP L Witt, G T Spear, D O Helgeson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasiasA R Moser, E M Mattes, W F Dove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapyJ L de Jong, N L Farner, B R Javorsky, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 4, 1993
Modulation of target-cell culture conditions alters susceptibility to lymphocyte-mediated lysisM R Albertini, S P Howard, P Fisch, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy modelS C Helfand, S A Soergel, R L Donner, et al.
AIDS (London, England)|March 1, 1991
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individualsP L Witt, G T Spear, M J Lindstrom, et al.
Journal of Biological Response Modifiers|October 1, 1990
Limiting dilution analysis of lymphokine-activated killer cell precursor frequencies in peripheral blood lymphocytes of cancer patients receiving interleukin-2 therapyM R Albertini, K R Oettel, G Weil-Hillman, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|December 8, 1998
Heterogeneous expression of the lipocalin NGAL in primary breast cancersS P Stoesz, A Friedl, J D Haag, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 1994
The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitizationC J McGinn, E M Miller, M J Lindstrom, et al.
Cancer Research|September 15, 1993
Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometryJ N Sarkaria, D F Gibson, V C Jordan, et al.
Journal of Interferon Research|August 1, 1990
Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophagesP L Witt, G T Spear, D O Helgeson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasiasA R Moser, E M Mattes, W F Dove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapyJ L de Jong, N L Farner, B R Javorsky, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 4, 1993
Modulation of target-cell culture conditions alters susceptibility to lymphocyte-mediated lysisM R Albertini, S P Howard, P Fisch, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy modelS C Helfand, S A Soergel, R L Donner, et al.
AIDS (London, England)|March 1, 1991
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individualsP L Witt, G T Spear, M J Lindstrom, et al.
Journal of Biological Response Modifiers|October 1, 1990
Limiting dilution analysis of lymphokine-activated killer cell precursor frequencies in peripheral blood lymphocytes of cancer patients receiving interleukin-2 therapyM R Albertini, K R Oettel, G Weil-Hillman, et al.
Pageof 5